Autoimmune Pancreatitis.

Link to article at PubMed

Related Articles

Autoimmune Pancreatitis.

Am J Gastroenterol. 2018 Jun 18;:

Authors: Nagpal SJS, Sharma A, Chari ST

Abstract
Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.

PMID: 29910463 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *